PubMed (RefSeq) for id: 32967607

Year	Number of Results
1990	1
1993	1
1994	2
1996	2
1998	1
2000	3
2001	3
2002	1
2003	2
2004	1
2005	2
2006	2
2007	4
2008	6
2009	8
2010	4
2011	2
2012	2
2013	2
2014	2
2015	2
2016	2
2017	4
2019	3
2020	3
2021	2
2022	3
2023	5
2024	0

1

Long non-coding RNA NMRAL2P promotes glycolysis and reduces ROS in head and neck tumors by interacting with the ENO1 protein and promoting GPX2 transcription.

Nie Q, Cao H, Yang J, Liu T, Wang B. Nie Q, et al. PeerJ. 2023 Oct 2;11:e16140. doi: 10.7717/peerj.16140. eCollection 2023. PeerJ. 2023. PMID: 37810778 Free PMC article.

2

ACVRL1 drives resistance to multitarget tyrosine kinase inhibitors in colorectal cancer by promoting USP15-mediated GPX2 stabilization.

Lu X, Liu R, Liao Y, Cui L, Sun H, Zhang D, Wang B, Fang L, Guan X, Yao Y, Liu C, Zhang Y. Lu X, et al. BMC Med. 2023 Sep 25;21(1):366. doi: 10.1186/s12916-023-03066-4. BMC Med. 2023. PMID: 37743483 Free PMC article.

3

Glutathione peroxidase 2 knockdown suppresses gastric cancer progression and metastasis via regulation of kynurenine metabolism.

Xu H, Hu C, Wang Y, Shi Y, Yuan L, Xu J, Zhang Y, Chen J, Wei Q, Qin J, Xu Z, Cheng X. Xu H, et al. Oncogene. 2023 Jun;42(24):1994-2006. doi: 10.1038/s41388-023-02708-4. Epub 2023 May 3. Oncogene. 2023. PMID: 37138031 Free PMC article.

4

Glutathione peroxidase 2: A key factor in the development of microsatellite instability in colon cancer.

Cui Z, Xu L, Wu H, Wang M, Lu L, Wu S. Cui Z, et al. Pathol Res Pract. 2023 Mar;243:154372. doi: 10.1016/j.prp.2023.154372. Epub 2023 Feb 12. Pathol Res Pract. 2023. PMID: 36796200 Free article.

5

Side-by-side comparison of recombinant human glutathione peroxidases identifies overlapping substrate specificities for soluble hydroperoxides.

Schwarz M, Löser A, Cheng Q, Wichmann-Costaganna M, Schädel P, Werz O, Arnér ES, Kipp AP. Schwarz M, et al. Redox Biol. 2023 Feb;59:102593. doi: 10.1016/j.redox.2022.102593. Epub 2023 Jan 2. Redox Biol. 2023. PMID: 36608588 Free PMC article.

6

Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS‑mutated lung cancer cells.

Wang M, Chen X, Fu G, Ge M. Wang M, et al. Oncol Rep. 2022 Dec;48(6):207. doi: 10.3892/or.2022.8422. Epub 2022 Oct 12. Oncol Rep. 2022. PMID: 36222298 Free PMC article.

7

Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer.

Ren Z, Liang H, Galbo PM Jr, Dharmaratne M, Kulkarni AS, Fard AT, Aoun ML, Martinez-Lopez N, Suyama K, Benard O, Zheng W, Liu Y, Albanese J, Zheng D, Mar JC, Singh R, Prystowsky MB, Norton L, Hazan RB. Ren Z, et al. Proc Natl Acad Sci U S A. 2022 Feb 22;119(8):e2107266119. doi: 10.1073/pnas.2107266119. Proc Natl Acad Sci U S A. 2022. PMID: 35193955 Free PMC article.

8

Iron-mediated epigenetic activation of NRF2 targets.

Horniblow RD, Pathak P, Balacco DL, Acharjee A, Lles E, Gkoutos G, Beggs AD, Tselepis C. Horniblow RD, et al. J Nutr Biochem. 2022 Mar;101:108929. doi: 10.1016/j.jnutbio.2021.108929. Epub 2021 Dec 23. J Nutr Biochem. 2022. PMID: 34954079 Free article.

9

Reduced Expression Level of GPX2 in T1 Bladder Cancer and its Role in Early-phase Invasion of Bladder Cancer.

Minato A, Noguchi H, Ohnishi R, Tomisaki I, Nakayama T, Fujimoto N. Minato A, et al. In Vivo. 2021 Mar-Apr;35(2):753-759. doi: 10.21873/invivo.12316. In Vivo. 2021. PMID: 33622868 Free PMC article.

10

Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma.

Du H, Chen B, Jiao NL, Liu YH, Sun SY, Zhang YW. Du H, et al. Oxid Med Cell Longev. 2020 Mar 6;2020:7370157. doi: 10.1155/2020/7370157. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32215178 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

68 results

Results by year